Matches in SemOpenAlex for { <https://semopenalex.org/work/W2322414131> ?p ?o ?g. }
Showing items 1 to 83 of
83
with 100 items per page.
- W2322414131 endingPage "42" @default.
- W2322414131 startingPage "42" @default.
- W2322414131 abstract "Purpose: 5α reductase, dutasteride, has widely used to treat enlarged prostate (BPH). By suppressing the conversion of testosterone to dihydrotestosterone it decreases serum prostate-specific antigen (PSA) which is very important screening marker for prostate cancer. We evaluate the early serum PSA changes after dutasteride treatment to Korean BPH patients. Materials and Methods: A total 159 men with a clinical diagnosis of BPH and no evidence of prostate cancer were enrolled. They were treated with dutasteride 0.5mg daily for 12 months. Serum PSA was evaluated at 2, 6, and 12 months after the medication. Result: Dutasteride statistically significantly reduced serum PSA to 0.70±0.52, 0.64±0.35, and 0.59±0.49 from baseline level at 2, 6, and 12 months after the medication, respectively. However, there was no statistical significance among the three groups in serum PSA changes after dutasteride. There were statistically significant correlations between a high pre-treatment serum PSA level and a large reduction of follow-up PSA levels at 2, 6, and 12 months after dutasteride treatment. Conclusions: The reduction of serum PSA is variable in patients to patients at 2, 6, and 12 months after dutasteride treatment. The patient with high initial serum PSA revealed a large reduction of serum PSA level after treatment. The traditional concept that follow-up serum PSA level should be doubled for prostate cancer screening may overestimate real serum PSA level within 12 months in Korean men receiving 5α reductase inhibitors. (J Korean Continence Soc 2008;12:42-47)" @default.
- W2322414131 created "2016-06-24" @default.
- W2322414131 creator A5010542458 @default.
- W2322414131 creator A5014155546 @default.
- W2322414131 creator A5045528056 @default.
- W2322414131 date "2008-01-01" @default.
- W2322414131 modified "2023-09-27" @default.
- W2322414131 title "The Effect of Dutasteride on Serum Prostate-specific Antigen (PSA) in Patients with Benign Prostate Hypertrophy" @default.
- W2322414131 cites W1563460086 @default.
- W2322414131 cites W1966236678 @default.
- W2322414131 cites W1967318128 @default.
- W2322414131 cites W1973883103 @default.
- W2322414131 cites W1983944422 @default.
- W2322414131 cites W1986472546 @default.
- W2322414131 cites W2005758976 @default.
- W2322414131 cites W2013120447 @default.
- W2322414131 cites W2053552044 @default.
- W2322414131 cites W2059964304 @default.
- W2322414131 cites W2093298704 @default.
- W2322414131 cites W2105000714 @default.
- W2322414131 cites W2108917769 @default.
- W2322414131 cites W2144680317 @default.
- W2322414131 cites W2150144789 @default.
- W2322414131 cites W2156812459 @default.
- W2322414131 cites W2768448209 @default.
- W2322414131 cites W3221563 @default.
- W2322414131 doi "https://doi.org/10.5213/jkcs.2008.12.1.42" @default.
- W2322414131 hasPublicationYear "2008" @default.
- W2322414131 type Work @default.
- W2322414131 sameAs 2322414131 @default.
- W2322414131 citedByCount "3" @default.
- W2322414131 countsByYear W23224141312018 @default.
- W2322414131 countsByYear W23224141312019 @default.
- W2322414131 crossrefType "journal-article" @default.
- W2322414131 hasAuthorship W2322414131A5010542458 @default.
- W2322414131 hasAuthorship W2322414131A5014155546 @default.
- W2322414131 hasAuthorship W2322414131A5045528056 @default.
- W2322414131 hasBestOaLocation W23224141311 @default.
- W2322414131 hasConcept C121608353 @default.
- W2322414131 hasConcept C126322002 @default.
- W2322414131 hasConcept C126894567 @default.
- W2322414131 hasConcept C2776235491 @default.
- W2322414131 hasConcept C2777911890 @default.
- W2322414131 hasConcept C2778878792 @default.
- W2322414131 hasConcept C2779279991 @default.
- W2322414131 hasConcept C2779881493 @default.
- W2322414131 hasConcept C2780192828 @default.
- W2322414131 hasConcept C2781406297 @default.
- W2322414131 hasConcept C71315377 @default.
- W2322414131 hasConcept C71924100 @default.
- W2322414131 hasConceptScore W2322414131C121608353 @default.
- W2322414131 hasConceptScore W2322414131C126322002 @default.
- W2322414131 hasConceptScore W2322414131C126894567 @default.
- W2322414131 hasConceptScore W2322414131C2776235491 @default.
- W2322414131 hasConceptScore W2322414131C2777911890 @default.
- W2322414131 hasConceptScore W2322414131C2778878792 @default.
- W2322414131 hasConceptScore W2322414131C2779279991 @default.
- W2322414131 hasConceptScore W2322414131C2779881493 @default.
- W2322414131 hasConceptScore W2322414131C2780192828 @default.
- W2322414131 hasConceptScore W2322414131C2781406297 @default.
- W2322414131 hasConceptScore W2322414131C71315377 @default.
- W2322414131 hasConceptScore W2322414131C71924100 @default.
- W2322414131 hasIssue "1" @default.
- W2322414131 hasLocation W23224141311 @default.
- W2322414131 hasOpenAccess W2322414131 @default.
- W2322414131 hasPrimaryLocation W23224141311 @default.
- W2322414131 hasRelatedWork W1997350508 @default.
- W2322414131 hasRelatedWork W2007200257 @default.
- W2322414131 hasRelatedWork W2110860120 @default.
- W2322414131 hasRelatedWork W2155761296 @default.
- W2322414131 hasRelatedWork W2313477093 @default.
- W2322414131 hasRelatedWork W2336014336 @default.
- W2322414131 hasRelatedWork W2588879340 @default.
- W2322414131 hasRelatedWork W2606218154 @default.
- W2322414131 hasRelatedWork W2738425090 @default.
- W2322414131 hasRelatedWork W3163649103 @default.
- W2322414131 hasVolume "12" @default.
- W2322414131 isParatext "false" @default.
- W2322414131 isRetracted "false" @default.
- W2322414131 magId "2322414131" @default.
- W2322414131 workType "article" @default.